| Citation: | Branch of Organ Transplantation of Chinese Medical Association, National Quality Management and Control Center for Lung Transplantation. Guideline on the application of extracorporeal membrane oxygenation during the perioperative period of lung transplantation(2019 edition)[J]. ORGAN TRANSPLANTATION, 2019, 10(4): 402-409. doi: 10.3969/j.issn.1674-7445.2019.04.009
|
| [1] |
LOOR G, SIMPSON L, PARULEKAR A. Bridging to lung transplantation with extracorporeal circulatory support: when or when not?[J]. J Thorac Dis, 2017, 9(9):3352-3361. DOI: 10.21037/jtd.2017.08.117.
|
| [2] |
KEARNS SK, HERNANDEZ OO. "Awake" extracorporeal membrane oxygenation as a bridge to lung transplant[J]. AACN Adv Crit Care, 2016, 27(3):293-300. doi: 10.4037/aacnacc2016792
|
| [3] |
HAKIM AH, AHMAD U, MCCURRY KR, et al. Contemporary outcomes of extracorporeal membrane oxygenation used as bridge to lung transplantation[J]. Ann Thorac Surg, 2018, 106(1):192-198. DOI: 10.1016/j.athoracsur.2018.02.036.
|
| [4] |
LEE SG, SON BS, KANG PJ, et al. The feasibility of extracorporeal membrane oxygenation support for inter-hospital transport and as a bridge to lung transplantation[J]. Ann Thorac Cardiovasc Surg, 2014, 20(1):26-31. doi: 10.5761/atcs.oa.12.00203
|
| [5] |
龙村.体外膜肺氧合循环支持专家共识[J].中国体外循环杂志, 2014, 12(2):65-67. DOI: 10.13498/j.cnki.chin.j.ecc.2014.02.01.
LONG C. Expert consensus on extracorporeal membrane oxygenation circulation support[J]. Chin J Extra Circ, 2014, 12(2):65-67.DOI: 10.13498/j.cnki.chin.j.ecc.2014.02.01.
|
| [6] |
REEB J, OLLAND A, RENAUD S, et al. Vascular access for extracorporeal life support: tips and tricks[J]. J Thorac Dis, 2016, 8(Suppl 4):S353-S363. DOI: 10.21037/jtd.2016.04.42.
|
| [7] |
DOUFLÉ G, FERGUSON ND. Monitoring during extracorporeal membrane oxygenation[J]. Curr OpinCrit Care, 2016, 22(3):230-238. DOI: 10.1097/MCC.0000000000000309.
|
| [8] |
LUYT CE, BRÉCHOT N, DEMONDION P, et al. Brain injury during venovenous extracorporeal membrane oxygenation[J]. Intensive Care Med, 2016, 42(5):897-907. DOI: 10.1007/s00134-016-4318-3.
|
| [9] |
CHEN H, YU RG, YIN NN, et al. Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review[J]. Crit Care, 2014, 18(6):675. DOI: 10.1186/s13054-014-0675-x.
|
| [10] |
GARCIA JP, KON ZN, EVANS C, et al. Ambulatory veno-venous extracorporeal membrane oxygenation: innovation and pitfalls[J]. J Thorac Cardiovasc Surg, 2011, 142(4):755-761. DOI: 10.1016/j.jtcvs.2011.07.029.
|
| [11] |
IUS F, SOMMER W, TUDORACHE I, et al. Veno-veno-arterial extracorporeal membrane oxygenation for respiratory failure with severe haemodynamic impairment: technique and early outcomes[J]. Interact Cardiovasc Thorac Surg, 2015, 20(6):761-767. DOI: 10.1093/icvts/ivv035.
|
| [12] |
PARK BW, LEE SR, LEE MH, et al. Short stature is associated with the development of lower limb ischaemia during extracorporeal life support[J]. Perfusion, 2018, 33(5):383-389. DOI: 10.1177/0267659118755273.
|
| [13] |
MCRAE K, DE PERROT M. Principles and indications of extracorporeal life support in general thoracic surgery[J]. J Thorac Dis, 2018, 10(Suppl 8):S931-S946. DOI: 10.21037/jtd.2018.03.116.
|
| [14] |
PORTEOUS MK, LEE JC. Primary graft dysfunction after lung transplantation[J]. Clin Chest Med, 2017, 38(4):641-654. DOI: 10.1016/j.ccm.2017.07.005.
|
| [15] |
MULVIHILL MS, YEROKUN BA, DAVIS RP, et al. Extracorporeal membrane oxygenation following lung transplantation: indications and survival[J]. J Heart Lung Transplant, 2017: S1053-2498(17)31880-6. DOI: 10.1016/j.healun.2017.06.014.
|
| [16] |
SHARGALL Y, GUENTHER G, AHYA VN, et al. Report of the ISHLT Working Group on primary lung graft dysfunction part Ⅵ: treatment[J]. J Heart Lung Transplant, 2005, 24(10):1489-1500. doi: 10.1016/j.healun.2005.03.011
|
| [17] |
BRODIE D, BACCHETTA M. Extracorporeal membrane oxygenation for ARDS in adults[J]. N Engl J Med, 2011, 365(20):1905-1914. DOI: 10.1056/NEJMct1103720.
|
| [18] |
GULACK BC, HIRJI SA, HARTWIG MG. Bridge to lung transplantation and rescue post-transplant: the expanding role of extracorporeal membrane oxygenation[J]. J Thorac Dis, 2014, 6(8):1070-1079. DOI: 10.3978/j.issn.2072-1439.2014.06.04.
|
| [19] |
CASTLEBERRY AW, HARTWIG MG, WHITSON BA. Extracorporeal membrane oxygenation post lung transplantation[J]. Curr Opin Organ Transplant, 2013, 18(5):524-530. DOI: 10.1097/MOT.0b013e328365197e.
|
| [20] |
ABRAMS D, BRODIE D, ARCASOY SM. Extracorporeal life support in lung transplantation[J]. Clin Chest Med, 2017, 38(4):655-666. DOI: 10.1016/j.ccm.2017.07.006.
|
| [21] |
MULLA H, LAWSON G, VON ANREP C, et al. In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation[J]. Perfusion, 2000, 15(1):21-26. doi: 10.1177/026765910001500104
|
| [22] |
AHSMAN MJ, HANEKAMP M, WILDSCHUT ED, et al. Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates[J]. Clin Pharmacokinet, 2010, 49(6):407-419. DOI: 10.2165/11319970-000000000-00000.
|
| [23] |
WAGNER D, PASKO D, PHILLIPS K, et al. In vitro clearance of dexmedetomidine in extracorporeal membrane oxygenation[J]. Perfusion, 2013, 28(1):40-46. DOI: 10.1177/0267659112456894.
|
| [24] |
SHEKAR K, ROBERTS JA, MULLANY DV, et al. Increased sedation requirements in patients receiving extracorporeal membrane oxygenation for respiratory and cardiorespiratory failure[J]. Anaesth Intensive Care, 2012, 40(4):648-655. doi: 10.1177/0310057X1204000411
|
| [25] |
HA MA, SIEG AC. Evaluation of altered drug pharmacokinetics in critically Ill adults receiving extracorporeal membrane oxygenation[J]. Pharmacotherapy, 2017, 37(2):221-235. DOI: 10.1002/phar.1882.
|
| [26] |
ABRAMS D, JAVIDFAR J, FARRAND E, et al. Early mobilization of patients receiving extracorporeal membrane oxygenation: a retrospective cohort study[J]. Crit Care, 2014, 18(1):R38. DOI: 10.1186/cc13746.
|
| [27] |
KO Y, CHO YH, PARK YH, et al. Feasibility and safety of early physical therapy and active mobilization for patients on extracorporeal membrane oxygenation[J]. ASAIO J, 2015, 61(5):564-568. DOI: 10.1097/MAT.0000000000000239.
|
| [28] |
LINKINS LA, DANS AL, MOORES LK, et al. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines[J]. Chest, 2012, 141(2 Suppl):e495S-e530S. DOI: 10.1378/chest.11-2303.
|
| [29] |
MARASCO SF, LUKAS G, MCDONALD M, et al. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients[J]. Heart Lung Circ, 2008, 17 (Suppl 4):S41-S47. DOI: 10.1016/j.hlc.2008.08.009.
|
| [30] |
AISSAOUI N, EL-BANAYOSY A, COMBES A. How to wean a patient from veno-arterial extracorporeal membrane oxygenation[J]. Intensive Care Med, 2015, 41(5):902-905. DOI: 10.1007/s00134-015-3663-y.
|
| [31] |
AISSAOUI N, LUYT CE, LEPRINCE P, et al. Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock[J]. Intensive Care Med, 2011, 37(11):1738-1745. DOI: 10.1007/s00134-011-2358-2.
|
| [32] |
MENAKER J, TABATABAI A, RECTOR R, et al. Incidence of cannula-associated deep vein thrombosis after veno-venous extracorporeal membrane oxygenation[J]. ASAIO J, 2017, 63(5):588-591. DOI: 10.1097/MAT.0000000000000539.
|
Figures(1)
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: